CLINICAL_TRIALS
trial_result
· 2025-09-26
Clinical Trial Update: Taxoprexin Treatment for Advanced Skin Melanoma [Phase 2]
Summary
A Phase 2 trial update reports completion of testing Taxoprexin in patients with advanced/metastatic melanoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: American Regent, Inc. | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED